miR-1228-3p |
EVs derived from cancer-associated fibroblasts |
Promoting HCC proliferation, migration, and invasion |
Activating the PLAC8-mediated PI3K/AKT pathway |
Zhang J. et al. (2023)
|
miR-375 |
EVs from bone marrow mesenchymal stem cells |
Hindering HCC progression |
Activating the HOXB3-mediated Wnt/β-Catenin pathway |
Yu et al. (2022)
|
miR-338-3p |
EVs from bone marrow mesenchymal stem cells |
Inhibiting HCC proliferation, invasion, migration, and inducing apoptosis |
Targeting ETS1 |
Li J. et al. (2021)
|
miR-451a |
EVs from bone marrow mesenchymal stem cells |
Reversing paclitaxel resistance and promoting apoptosis in HCC cells |
Suppressing ADAM10 expression and epithelial-mesenchymal transition |
Xu et al. (2021)
|
CircZFR |
EVs derived from cancer-associated fibroblasts |
Enhancing cisplatin resistance in HCC cells |
Impeding the STAT3/NF-κB pathway |
Zhou J. et al. (2022)
|
CircTTLL5 |
EVs derived from HCC cells |
Promoting HCC cell proliferation, in vitro metastasis, and tumor growth in nude mice |
miR-136-5p/KIAA1522 signaling pathway |
Liu et al. (2023)
|
Circ_002136 |
EVs derived from HCC cells |
Stimulating HCC progression |
miR-19a-3p/RAB1A pathway |
Yuan et al. (2022)
|
miR-25 |
EVs derived from HCC cells |
Promoting HCC progression |
Downregulating SIK1 expression and enhancing the Wnt/β-catenin pathway |
Fu et al. (2022)
|
LINC00161 |
EVs derived from HCC cells |
Leading to increased proliferation, migration, and angiogenesis of HCC cells |
Activating the ROCK2 signal by inhibiting miR-590-3p |
You et al. (2021)
|
miR-30a-3p |
EVs derived from HCC cells |
Reducing the migration, invasion, and metastasis ability of HCC cells |
Targeting SNAP23 |
Liu et al. (2021)
|
miR-15b |
EVs secreted by As-THP-1 cells |
Promoting HCC cells proliferation, migration, and invasion |
Through the Hippo pathway |
Li W. et al. (2021)
|
circGSE1 |
EVs derived from HCC cells |
Promoting the progression of HCC |
Inducing Tregs enrichment and inhibiting anti-tumor immune responses via the miR-324-5p/TGFBR1/Smad3 pathway |
Huang et al. (2022)
|
miR-452-5p |
EVs derived from HCC cells |
Enhancing the migration, invasion, and metastasis of HCC cells |
Targeting TIMP3 to induce M2 macrophage polarization |
Zongqiang et al. (2022)
|
miR-660-5p |
EVs derived from M2 macrophage |
Promoting HCC progression |
Regulating KLF3 expression |
Tian et al. (2021)
|
miR-148a-3p |
EVs derived from hepatic stellate cells |
Impeding HCC malignancy |
Through the PI3K/Akt/ITGA5 signaling pathway |
Zhang X. et al. (2022)
|
circWDR25 |
EVs derived from hepatic stellate cells |
Stimulating the proliferation and invasion of HCC cells |
Through activating miR-4474-3p/ALOX15 and epithelial-mesenchymal transition pathway |
Liu et al. (2022)
|